Does UPADACITINIB Cause Therapeutic response shortened? 83 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 83 reports of Therapeutic response shortened have been filed in association with UPADACITINIB (Rinvoq). This represents 0.1% of all adverse event reports for UPADACITINIB.
83
Reports of Therapeutic response shortened with UPADACITINIB
0.1%
of all UPADACITINIB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Therapeutic response shortened From UPADACITINIB?
Of the 83 reports, 7 (8.4%) required hospitalization.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 83 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which UPADACITINIB Alternatives Have Lower Therapeutic response shortened Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL